Table 3. Select clinical reports and... | American Society of Hematology

Table 3.

Select clinical reports and outcomes of rituximab and eculizumab in CAPS

	No. of patients	Outcome
Rituximab
Berman et al¹¹	20	75% recovered
Single case reports^7,8,48-59	14	57% recovered
Eculizumab
Single case reports^{5,11,48,49,57,60-62}	8	88% recovered

	No. of patients	Outcome
Rituximab
Berman et al¹¹	20	75% recovered
Single case reports^7,8,48-59	14	57% recovered
Eculizumab
Single case reports^{5,11,48,49,57,60-62}	8	88% recovered